>
Fa   |   Ar   |   En
   Strong Type 1,but Impaired Type 2,Immune Responses Contribute to Orientia tsutsugamushi-Induced Pathology in Mice  
   
نویسنده soong l. ,wang h. ,shelite t.r. ,liang y. ,mendell n.l. ,sun j. ,gong b. ,valbuena g.a. ,bouyer d.h. ,walker d.h.
منبع plos neglected tropical diseases - 2014 - دوره : 8 - شماره : 9
چکیده    Scrub typhus is a neglected,but important,tropical disease,which puts one-third of the world's population at risk. the disease is caused by orientia tsutsugamushi,an obligately intracellular gram-negative bacterium. dysregulation in immune responses is known to contribute to disease pathogenesis; however,the nature and molecular basis of immune alterations are poorly defined. this study made use of a newly developed murine model of severe scrub typhus and focused on innate regulators and vascular growth factors in o. tsutsugamushi-infected liver,lungs and spleen. we found no activation or even reduction in base-line expression for multiple molecules (il-7,il-4,il-13,gata3,ror-γt,and cxcl12) at 2,6 and 10 days post-infection. this selective impairment in type 2-related immune responses correlated with a significant activation of the genes for il-1β,il-6,il-10,tnf-α,ifn-γ,as well as cxcr3- and cxcr1-related chemokines in inflamed tissues. the elevated angiopoietin (ang)-2 expression and ang-2/ang-1 ratios suggested excessive inflammation and the loss of endothelial integrity. these alterations,together with extensive recruitment of myeloperoxidase (mpo)-expressing neutrophils and the influx of cd3+ t cells,contributed to acute tissue damage and animal death. this is the first report of selective alterations in a panel of immune regulators during early o. tsutsugamushi infection in intravenously inoculated c57bl/6 mice. our findings shed new light on the pathogenic mechanisms associated with severe scrub typhus and suggest potential targets for therapeutic investigation. © 2014 soong et al.
آدرس department of microbiology and immunology,university of texas medical branch,galveston,tx,united states,department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of microbiology and immunology,university of texas medical branch,galveston,tx, United States, department of microbiology and immunology,university of texas medical branch,galveston,tx,united states,department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of microbiology and immunology,university of texas medical branch,galveston,tx, United States, department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of microbiology and immunology,university of texas medical branch,galveston,tx, United States, department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States, department of pathology,center for biodefense and emerging infectious diseases,center for tropical diseases,sealy center for vaccine development,institute of human infections and immunity,university of texas medical branch,galveston,tx, United States
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved